Skip to content

Syndax Pharmaceuticals SNDX Change in Inventories

Change in Inventories at other companies

Biogen logo
BiogenBIIB
-$116.2M-87.4%
Incyte logo
IncyteINCY
$12.23M-57.2%
AbbVie logo
AbbVieABBV
$184M+18.7%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$4M+300%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
-$2.24M-1,043%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$4.14M+728%

Other financials

Income statement

See full
Revenue$64.9M+224%
Operating income-$34.2M+59.2%
Net income-$42.7M+49.7%
EPS (diluted)-$0.48+51.0%

Balance sheet

See full
Cash & equivalents$130.9M-15.0%
Total debt$350.5M+4.2%
Total equity$41.6M-80.6%
Total assets$472.7M-26.2%

Cash flow

See full
Operating cash flow-$50.3M+47.1%
CapEx$46.8K
Free cash flow-$80.8M-17.6%

Valuation

See full
Market cap$1.77B+95.0%

Profitability

See full
Operating margin-102.8%-47.8pp
Net margin-111.9%-51.5pp
FCF margin-187.2%-85.4pp

Returns & leverage

See full
Return on equity-189.5%-8,509pp
Debt / equity8.4×+6.9×
Current ratio5.5×-0.3×

Where this comes from

Reported directly by Syndax Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Syndax Pharmaceuticals's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Syndax Pharmaceuticals's change in inventories?
Syndax Pharmaceuticals (SNDX) reported change in inventories of $2.06M in Q1 2026.
How has Syndax Pharmaceuticals's change in inventories changed year-over-year?
Syndax Pharmaceuticals's change in inventories decreased by 50.8% year-over-year, from $4.19M to $2.06M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.